Using this approach we have identified the nuclear hormone receptor PPARG, the metalloproteinase ADAMTS5, and the aldo-keto reductase AKR1B10 as potential drug targets for treatment of osteoporosis and obesity. The gene discussed is ADAMTS5; the disease is obesity due to melanocortin 4 receptor deficiency.